Please login to the form below

Not currently logged in
Email:
Password:

Clostridium difficile

This page shows the latest Clostridium difficile news and features for those working in and with pharma, biotech and healthcare.

Finch’s microbiota drug for C. diff gets FDA breakthrough status

Finch’s microbiota drug for C. diff gets FDA breakthrough status

Boost for firm as it races rivals in microbiome space. Finch Therapeutics has won a breakthrough designation (BTD) from the FDA for CP101, a drug for serious Clostridium difficile infections based

Latest news

More from news
Approximately 4 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    Nestlé has been granted commercial rights (outside the USA and Canada) to a range of products focusing on Clostridium difficile infections (CDI) including SER 109 and SER 262 as well as ... 32, 000. Seres Therapeutics/ Nestle Health Science.

  • Astellas: Ten years young Astellas: Ten years young

    class of OAB treatments to emerge in over 30 years, the antifungal Mycamine (micafungin) and the anti-infective Dificlir - the first new treatment in 50 years for clostridium difficile or c.

  • Cubist: Meeting the challenge in antibiotics Cubist: Meeting the challenge in antibiotics

    Pneumonia Clostridium difficile-associated diarrhoea (CDAD).  .  x. bevenopran. Opioid-induced constipation (OIC).  .

  • Pharma deals during December 2014 Pharma deals during December 2014

    The Optimer acquisition brought to Cubist an approved antibacterial drug for the treatment of Clostridium difficile-associated diarrhoea (CDAD) called DIFICID (fidaxomicin).  .

  • Pharma deals during July 2013 Pharma deals during July 2013

    Cubist had already developed a relationship with Optimer through their 2011 co-promotion agreement for Dificid (fidaxomicin), for the treatment of Clostridium difficile-associated diarrhoea (CDAD) in adults 18 years of

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics